Nanoform is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about Nanoform. Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.
Company size
11-50 employees
Headquarters
Helsinki, Southern Finland